Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials

ClinicalLIVEUpdated 18 Nov 2026

New Clinical Trials

Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.

Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.

Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777

Signals

What the register says this week, and why it matters if you sell into it.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
  3. 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
  4. A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

Export the full new clinical trials

777 rows as a .csv. Free. Every field, with its source link.

Country
Phase
Study type
777 / 777 trials
PostedSponsorStudyPhaseStatus
28 Oct 2026Keymed Biosciences Co.LtdChinaStudy of Single and Multiple Ascending Doses of CM551 in Healthy ParticipantsPhase 1Not Yet Recruiting28 Oct 2026Laboratorios Silanes S.A. de C.V.MexicoStudy to Evaluate the Efficacy and Safety of Dexketoprofen / Butylscopolamine vs Dexketoprofen in Treatment of Primary DysmenorrheaPhase 3Completed28 Oct 2026MED-EL Elektromedizinische Geräte GmbHAustria, Belgium, GermanyMi2000 TICI Follow-upRecruiting28 Oct 2026Medtronic - MITGHugo™ RAS Urology Post-Market Clinical StudyNot Yet Recruiting28 Oct 2026Merck Sharp & Dohme LLCA Clinical Study of MK-7962 in Chinese Participants With Pulmonary Arterial Hypertension (MK-7962-022)Phase 4Not Yet Recruiting28 Oct 2026Minerais SASFranceSUVY VerSus SAccharose (SUVISA)Not applicableNot Yet Recruiting28 Oct 2026Murata Vios, Inc.United StatesMoni-Patch Temperature Data Collection for Algorithm Development During SurgeryNot applicableRecruiting28 Oct 2026Murata Vios, Inc.United StatesAccuracy of Moni-Patch Compared With Tympanic Temperature Monitoring in Adults at Risk of FeverNot applicableNot Yet Recruiting28 Oct 2026Nano-X ImagingIsraelEvaluation of the Diagnostic Potential of Nanox.ARC Tomosynthesis System for Different DiseasesNot applicableRecruiting28 Oct 2026Nordic NaturalsCanadaA Randomized, Double-blind, Placebo Controlled, Parallel Virtual Clinical Trial to Investigate the Efficacy of Marine Oil Products on Omega-3 Status in Healthy AdultsNot applicableRecruiting28 Oct 2026Novo Nordisk A/SChinaA Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in ChinaPhase 4Recruiting28 Oct 2026Nuvascular IncAustria, BulgariaThe NUVASCULAR HARBOR Occlusion Device EU StudyNot applicableNot Yet Recruiting28 Oct 2026Odyssey Therapeutics, Inc.United KingdomThe Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male ParticipantsPhase 1Recruiting28 Oct 2026Paulex Bio Inc.Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 DiabetesPhase 1, Phase 2Not Yet Recruiting28 Oct 2026PfizerUnited StatesA Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026Active Not Recruiting28 Oct 2026Philips Clinical & Medical Affairs GlobalUnited StatesPhilips Inflationary-Based Non-Invasive Blood Pressure Validation StudyRecruiting28 Oct 2026Precigen, IncUnited StatesZopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in ChildrenPhase 3Not Yet Recruiting28 Oct 2026Ray Therapeutics, Inc.United StatesStudy to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT)Phase 2, Phase 3Recruiting28 Oct 2026Regeneron PharmaceuticalsLinvoseltamab Versus Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone (Dara-Vcd) in Adult Participants With Newly Diagnosed Systemic Light Chain AmyloidosisPhase 3Not Yet Recruiting28 Oct 2026Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.AustriaPhase 1 Study to Evaluate RG002C0106 Injection in Healthy ParticipantsPhase 1Not Yet Recruiting28 Oct 2026Shanghai Hengrui Pharmaceutical Co., Ltd.ChinaHRS-4642 Combined With Antitumor Agents for the Treatment of Perioperative Pancreatic CancerPhase 3Not Yet Recruiting28 Oct 2026Shanghai Huaota Biopharmaceutical Co., Ltd.ChinaA Study of HB0056 in Adult Participants With Moderate to Severe AsthmaPhase 1, Phase 2Recruiting28 Oct 2026Siren BiotechnologyA Study of SRN-101 Gene Therapy in Adults With Recurrent High-Grade Glioma (ALERT-1)Phase 1, Phase 2Not Yet Recruiting28 Oct 2026Smith & Nephew, Inc.United StatesUtilizing RENASYS◊ DYNAFLOW Instillation Therapy System for Wound Management in Adults With Acute and Chronic WoundsNot applicableNot Yet Recruiting28 Oct 2026Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.ChinaThis Study Will Evaluate the Effect and Safety of 626 in Patients With CLEPhase 2Not Yet Recruiting28 Oct 2026Unilever R&DUnited StatesClinical Study to Evaluate the Impact of Nutraceutical Supplements in Participants With Self-Perceived Thinning HairNot applicableNot Yet Recruiting28 Oct 2026Varian, a Siemens Healthineers CompanyA Retrospective Registry of Intelliblate DUAL Channel Microwave AblationNot Yet Recruiting28 Oct 2026Wecare Probiotics Co., Ltd.ChinaDigestion and Absorption of Postbiotic Regulatory ProteinsNot applicableRecruiting27 Oct 2026AB Mauri (UK) Limited,United StatesA Study to Evaluate the Effects of a Supplement on Gut Comfort in GLP-1 Receptor Agonist UsersNot applicableCompleted27 Oct 2026AbbVieAustriaReal-World Study of Mirvetuximab Soravtansine in Adult Participants With Platinum-Resistant FRα-Positive Ovarian, Fallopian Tube, and Peritoneal CancerRecruiting27 Oct 2026AbbVieA Study to Learn How Effective, Safe, and Tolerable Upadacitinib is for Young Participants With Non-segmental VitiligoPhase 3Not Yet Recruiting27 Oct 2026Amneal Pharmaceuticals, LLCUnited StatesSafety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With HypogonadismPhase 3Recruiting27 Oct 2026Apreo Health, Inc.United StatesXenon MRI to Evaluate Changes to Lung Function Following Bronchoscopic Treatment of Air Trapping in EmphysemaEarly Phase 1Recruiting27 Oct 2026Axter Therapeutics (Beijing) Co., LtdChinaAXT-1003 Combination With Enzalutamide in Participants With mCRPCPhase 1Recruiting27 Oct 2026Beijing InnoCare Pharma Tech Co., Ltd.ChinaOrelabrutinib Plus ICP 248 vs Orelabrutinib for Relapsed/Refractory Marginal Zone LymphomaPhase 3Not Yet Recruiting27 Oct 2026BeOne MedicinesA First-in-Human Study of BG-92505 Alone or in Combination With Other Anti-cancer Agents in Patients With Advanced Solid TumorsPhase 1Not Yet Recruiting27 Oct 2026BIONEER CorporationSouth KoreaEfficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic AlopeciaNot applicableCompleted27 Oct 2026BlissBot, IncEvaluation of a Novel Quantum-Inspired Intervention (QII) for Children With Autism Spectrum Disorder: A Global Confirmatory StudyNot applicableNot Yet Recruiting27 Oct 2026Calypta Systems, Inc.United StatesConversational AI for Adult Flu Vaccination DecisionsNot applicableActive Not Recruiting27 Oct 2026ChinaNormChinaMask Instant Clinical StudyNot applicableCompleted27 Oct 2026Comeback Mobility IncPersonalized Weight-Bearing With Smart Crutch Tips After Surgery for Tibial Plateau FracturesNot applicableNot Yet Recruiting27 Oct 2026CooperVision International Limited (CVIL)United StatesClinical Performance and Outcomes After Toric Lens TransitionNot applicableNot Yet Recruiting27 Oct 2026CSPC Megalith Biopharmaceutical Co.,Ltd.A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SYS6062 in Patients With Advanced Solid Tumors.Phase 1, Phase 2Not Yet Recruiting27 Oct 2026Desentum OyGermanySafety, Tolerability And Pharmacodynamics of DM-101PX in Birch Pollen AllergyPhase 1Recruiting27 Oct 2026Grand Theravac Life Sciences (Hangzhou) Co., Ltd.A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)Phase 1, Phase 2Not Yet Recruiting27 Oct 2026GuangZhou Cellgenes Biotechnology Co., Ltd.ChinaSafety and Efficacy of CG-BM1 in Ischemic StrokePhase 1, Phase 2Recruiting27 Oct 2026Hanmi Pharmaceutical Company LimitedSouth KoreaA Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction PatientsPhase 3Recruiting27 Oct 2026Hansoh BioMedical R&D CompanyA Phase I Study of HS-20093 Injection in Combination Therapy in Non-Small Cell Lung CancerPhase 1Not Yet Recruiting27 Oct 2026Invivyd, Inc.Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination SyndromePhase 2Not Yet Recruiting27 Oct 2026Jiangsu Aosaikang Pharmaceutical Co., Ltd.ChinaASKC202 Plus Limertinib as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLCPhase 3Not Yet Recruiting

// How AOS uses this

Every row here is a potential account. AOS finds the ones that need what you sell, maps the decision makers and prepares the outreach for your approval.